Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Structure Therapeutics Inc.Structure Therapeutics Reports $33.98M Net Loss, Increases Research and Development Expenses in Latest Quarter
MEDICINOVA INCMediciNova Reports Significant Revenue Decline and Net Loss in Q3 2024
Dermata Therapeutics, Inc.Dermata Therapeutics Reports Net Loss of $3.2M in Q3 2024, Increases Research and Development Expenses
Energous CorpEnergous Corporation Reports Q3 2024 Financial Results, Net Loss of $3.4 Million
RenovoRx, Inc.RenovoRx Reports Improved Financials, Raises $17.2M in Private Placements, and Advances Clinical Trials
Microbot Medical Inc.Microbot Medical Inc. Reports Continued Operating Losses and Decrease in Total Assets and Shareholders' Equity
Armata Pharmaceuticals, Inc.Armata Pharmaceuticals Reports 142.7% Increase in Grant Revenue, Net Loss Decrease in Q3 2024
NSTS Bancorp, Inc.NSTS Bancorp Reports Improved Q3 Net Loss, Increased Lending and Assets
Enliven Therapeutics, Inc.Enliven Therapeutics Reports Increased Assets, Continued Operating Losses in Q3 2024
NATURAL ALTERNATIVES INTERNATIONAL INCNatural Alternatives International Reports Decline in Financial Performance, Net Loss Increases 185%
EVOLUTION PETROLEUM CORPEvolution Petroleum Reports 6.3% Revenue Growth, Net Income Increase in Q3 2024
KULR Technology Group, Inc.KULR Technology Group Reports 5% Q3 Revenue Growth, Improved Profitability, and Strategic Developments
CF Acquisition Corp. VIICF Acquisition Corp. VII Reports Financial Results for Q3 2024, Net Loss and Decreased Assets
MIDDLEFIELD BANC CORPMiddlefield Banc Corp. Reports Mixed Q3 and Nine-Month Results, Net Income Down 39% and 22.8%
Cantor Equity Partners, Inc.Cantor Equity Partners Reports Significant Financial Progress, Net Income Turnaround in Latest Quarter
GRAIL, Inc.GRAIL Reports 38% Revenue Growth, Net Loss of $125.7M in Q3 2024
LANDMARK BANCORP INCLandmark Bancorp Reports 36.6% Increase in Net Earnings for Q3 2024
Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals Reports Significant Revenue Growth, Net Loss in Q3 2024
BayFirst Financial Corp.BayFirst Financial Corp. Reports Mixed Financial Results for Q3 2024, Focuses on Core Business and Capital Strength
NEXTNAV INC.NextNav Inc. Reports 56.5% Revenue Growth, Improved Operating Loss in Q3 2024
Maplebear Inc.Instacart Reports 12% Revenue Growth, Returns to Profitability in Q3 2024
Elicio Therapeutics, Inc.Elicio Therapeutics Reports Net Loss of $18.8M, Increases Cash Reserves to $26M in Latest Quarter
Kronos Bio, Inc.Kronos Bio Reports Q3 Financial Results, Revenue Growth, and Strategic Developments
Equillium, Inc.Equillium Reports Revenue Growth, Improved Net Loss, and Strategic Focus on Lead Product Candidate
Immuneering CorpImmuneering Corporation Reports Net Loss and Decreased Cash Reserves in Latest 10-Q Filing